Phthalates and blood pressure in pregnancy

What the study says

Plain-English summary

Researchers measured urinary metabolites during pregnancy and compared them with repeated blood-pressure measurements and diagnosed hypertensive disorders.

The paper adds newer replacement chemicals to a field that historically focused on legacy phthalates.

Its value is in prospective measurement across pregnancy rather than a single retrospective exposure estimate.

Why it matters

Context

Replacement does not automatically mean well studied. Ingredient transparency matters because newer substitutes can have a thinner evidence base.

What it cannot prove

Limitations

This is observational research. Associations can be influenced by correlated exposures and other differences between participants, and do not establish that a metabolite caused an outcome.

Proportionate next steps

Practical actions

• Ask a clinician about pregnancy-specific concerns.
• Favor clearly disclosed formulas over vague substitution claims.
• Avoid assuming a replacement plasticizer is proven safer.

Read it yourself

Original source

Exposure to phthalates and replacements during pregnancy in association with gestational blood pressure and hypertensive disorders of pregnancy

DOI: 10.1016/j.envres.2025.121739